Analyst Ratings for AstraZeneca (AZN)
AZN Rating Summary
AZN Price Target Summary
- Highest: $4,925.00 (UBS)
- Lowest: $87.00 (Leerink Partners)
- Average: $1,088.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$1,088.90 (+1073.8%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2025 | BNP Paribas Exane | N/A | New Coverage | Outperform (N/A) |
75.00 (N/A) |
68.01 (92.77) |
36.41% | Details |
| 9/30/2024 | Erste Group | Hans Engel | Downgrade | Hold (Buy) |
N/A (N/A) |
77.62 (92.77) |
19.52% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
